HEADER TRANSCRIPTON/INHIBITOR 25-APR-22 7USI TITLE BRD2-BD1 IN COMPLEX WITH MDP5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 FRAGMENT: BD1; COMPND 5 SYNONYM: O27.1.1,REALLY INTERESTING NEW GENE 3 PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD2, KIAA9001, RING3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, ACETYLLYSINE BINDING POCKET, TRANSCRIPTON-INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.D.JAYASINGHE,D.R.RONNING REVDAT 2 25-OCT-23 7USI 1 REMARK REVDAT 1 18-JAN-23 7USI 0 JRNL AUTH B.SETHI,V.KUMAR,T.D.JAYASINGHE,Y.DONG,D.R.RONNING,H.A.ZHONG, JRNL AUTH 2 D.W.COULTER,R.I.MAHATO JRNL TITL TARGETING BRD4 AND PI3K SIGNALING PATHWAYS FOR THE TREATMENT JRNL TITL 2 OF MEDULLOBLASTOMA. JRNL REF J CONTROL RELEASE V. 354 80 2023 JRNL REFN ISSN 1873-4995 JRNL PMID 36599397 JRNL DOI 10.1016/J.JCONREL.2022.12.055 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.56 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 38306 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.190 REMARK 3 FREE R VALUE TEST SET COUNT : 1987 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.5600 - 6.0100 0.97 2584 144 0.1950 0.2209 REMARK 3 2 6.0000 - 4.7700 1.00 2594 142 0.1876 0.2020 REMARK 3 3 4.7700 - 4.1700 1.00 2629 142 0.1634 0.2105 REMARK 3 4 4.1700 - 3.7900 1.00 2577 141 0.1767 0.2470 REMARK 3 5 3.7900 - 3.5200 1.00 2605 147 0.2062 0.2339 REMARK 3 6 3.5200 - 3.3100 1.00 2638 141 0.2142 0.2546 REMARK 3 7 3.3100 - 3.1500 1.00 2592 143 0.2392 0.3412 REMARK 3 8 3.1500 - 3.0100 1.00 2598 144 0.2381 0.3400 REMARK 3 9 3.0100 - 2.8900 1.00 2568 137 0.2413 0.3429 REMARK 3 10 2.8900 - 2.7900 1.00 2627 145 0.2114 0.2610 REMARK 3 11 2.7900 - 2.7100 1.00 2591 140 0.2110 0.2094 REMARK 3 12 2.7100 - 2.6300 1.00 2597 141 0.2160 0.3190 REMARK 3 13 2.6300 - 2.5600 1.00 2559 140 0.2483 0.3439 REMARK 3 14 2.5600 - 2.5000 0.97 2560 140 0.2489 0.3014 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7USI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-APR-22. REMARK 100 THE DEPOSITION ID IS D_1000264806. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38336 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 35.560 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.12600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6JKE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM TARTRATE DIBASIC REMARK 280 DIHYDRATE PH 7.5 AND 20 % W/V PEG 1000, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 289.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 74.93600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 70 REMARK 465 PRO A 71 REMARK 465 MET A 72 REMARK 465 GLY B 70 REMARK 465 PRO B 71 REMARK 465 MET B 72 REMARK 465 GLY C 70 REMARK 465 PRO C 71 REMARK 465 MET C 72 REMARK 465 GLY D 70 REMARK 465 PRO D 71 REMARK 465 MET D 72 REMARK 465 GLY E 70 REMARK 465 PRO E 71 REMARK 465 MET E 72 REMARK 465 GLY F 70 REMARK 465 PRO F 71 REMARK 465 MET F 72 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 GLU C 183 CB CG CD OE1 OE2 REMARK 470 GLU E 183 CB CG CD OE1 OE2 REMARK 470 GLU F 183 CB CG CD OE1 OE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LEU C 110 C REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 85 -66.88 -105.65 REMARK 500 VAL B 85 -62.77 -102.24 REMARK 500 LEU C 108 -5.30 -145.22 REMARK 500 LEU C 110 72.43 -118.25 REMARK 500 VAL D 85 -62.37 -103.44 REMARK 500 VAL F 85 -63.10 -106.39 REMARK 500 REMARK 500 REMARK: NULL DBREF 7USI A 73 183 UNP P25440 BRD2_HUMAN 73 183 DBREF 7USI B 73 183 UNP P25440 BRD2_HUMAN 73 183 DBREF 7USI C 73 183 UNP P25440 BRD2_HUMAN 73 183 DBREF 7USI D 73 183 UNP P25440 BRD2_HUMAN 73 183 DBREF 7USI E 73 183 UNP P25440 BRD2_HUMAN 73 183 DBREF 7USI F 73 183 UNP P25440 BRD2_HUMAN 73 183 SEQADV 7USI GLY A 70 UNP P25440 EXPRESSION TAG SEQADV 7USI PRO A 71 UNP P25440 EXPRESSION TAG SEQADV 7USI MET A 72 UNP P25440 EXPRESSION TAG SEQADV 7USI GLY B 70 UNP P25440 EXPRESSION TAG SEQADV 7USI PRO B 71 UNP P25440 EXPRESSION TAG SEQADV 7USI MET B 72 UNP P25440 EXPRESSION TAG SEQADV 7USI GLY C 70 UNP P25440 EXPRESSION TAG SEQADV 7USI PRO C 71 UNP P25440 EXPRESSION TAG SEQADV 7USI MET C 72 UNP P25440 EXPRESSION TAG SEQADV 7USI GLY D 70 UNP P25440 EXPRESSION TAG SEQADV 7USI PRO D 71 UNP P25440 EXPRESSION TAG SEQADV 7USI MET D 72 UNP P25440 EXPRESSION TAG SEQADV 7USI GLY E 70 UNP P25440 EXPRESSION TAG SEQADV 7USI PRO E 71 UNP P25440 EXPRESSION TAG SEQADV 7USI MET E 72 UNP P25440 EXPRESSION TAG SEQADV 7USI GLY F 70 UNP P25440 EXPRESSION TAG SEQADV 7USI PRO F 71 UNP P25440 EXPRESSION TAG SEQADV 7USI MET F 72 UNP P25440 EXPRESSION TAG SEQRES 1 A 114 GLY PRO MET GLY ARG VAL THR ASN GLN LEU GLN TYR LEU SEQRES 2 A 114 HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN PHE SEQRES 3 A 114 ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 4 A 114 GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO MET SEQRES 5 A 114 ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN TYR SEQRES 6 A 114 TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN THR SEQRES 7 A 114 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR ASP SEQRES 8 A 114 ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE PHE SEQRES 9 A 114 LEU GLN LYS VAL ALA SER MET PRO GLN GLU SEQRES 1 B 114 GLY PRO MET GLY ARG VAL THR ASN GLN LEU GLN TYR LEU SEQRES 2 B 114 HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN PHE SEQRES 3 B 114 ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 4 B 114 GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO MET SEQRES 5 B 114 ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN TYR SEQRES 6 B 114 TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN THR SEQRES 7 B 114 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR ASP SEQRES 8 B 114 ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE PHE SEQRES 9 B 114 LEU GLN LYS VAL ALA SER MET PRO GLN GLU SEQRES 1 C 114 GLY PRO MET GLY ARG VAL THR ASN GLN LEU GLN TYR LEU SEQRES 2 C 114 HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN PHE SEQRES 3 C 114 ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 4 C 114 GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO MET SEQRES 5 C 114 ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN TYR SEQRES 6 C 114 TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN THR SEQRES 7 C 114 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR ASP SEQRES 8 C 114 ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE PHE SEQRES 9 C 114 LEU GLN LYS VAL ALA SER MET PRO GLN GLU SEQRES 1 D 114 GLY PRO MET GLY ARG VAL THR ASN GLN LEU GLN TYR LEU SEQRES 2 D 114 HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN PHE SEQRES 3 D 114 ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 4 D 114 GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO MET SEQRES 5 D 114 ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN TYR SEQRES 6 D 114 TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN THR SEQRES 7 D 114 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR ASP SEQRES 8 D 114 ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE PHE SEQRES 9 D 114 LEU GLN LYS VAL ALA SER MET PRO GLN GLU SEQRES 1 E 114 GLY PRO MET GLY ARG VAL THR ASN GLN LEU GLN TYR LEU SEQRES 2 E 114 HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN PHE SEQRES 3 E 114 ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 4 E 114 GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO MET SEQRES 5 E 114 ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN TYR SEQRES 6 E 114 TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN THR SEQRES 7 E 114 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR ASP SEQRES 8 E 114 ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE PHE SEQRES 9 E 114 LEU GLN LYS VAL ALA SER MET PRO GLN GLU SEQRES 1 F 114 GLY PRO MET GLY ARG VAL THR ASN GLN LEU GLN TYR LEU SEQRES 2 F 114 HIS LYS VAL VAL MET LYS ALA LEU TRP LYS HIS GLN PHE SEQRES 3 F 114 ALA TRP PRO PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 4 F 114 GLY LEU PRO ASP TYR HIS LYS ILE ILE LYS GLN PRO MET SEQRES 5 F 114 ASP MET GLY THR ILE LYS ARG ARG LEU GLU ASN ASN TYR SEQRES 6 F 114 TYR TRP ALA ALA SER GLU CYS MET GLN ASP PHE ASN THR SEQRES 7 F 114 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO THR ASP SEQRES 8 F 114 ASP ILE VAL LEU MET ALA GLN THR LEU GLU LYS ILE PHE SEQRES 9 F 114 LEU GLN LYS VAL ALA SER MET PRO GLN GLU HET O6O A 201 27 HET PEG A 202 7 HET PEG A 203 7 HET PEG A 204 7 HET EDO A 205 4 HET PEG A 206 7 HET DMS A 207 4 HET EDO A 208 4 HET EDO A 209 4 HET EDO A 210 4 HET EDO A 211 4 HET CL A 212 1 HET NA A 213 1 HET O6O B 201 27 HET EDO B 202 4 HET EDO B 203 4 HET PEG B 204 7 HET EDO B 205 4 HET EDO B 206 4 HET EDO B 207 4 HET EDO B 208 4 HET DMS B 209 4 HET EDO B 210 4 HET EDO B 211 4 HET CL B 212 1 HET PEG C 201 7 HET DMS C 202 4 HET O6O C 203 27 HET EDO C 204 4 HET DMS C 205 4 HET EDO C 206 4 HET DMS C 207 4 HET CL C 208 1 HET O6O D 201 27 HET EDO D 202 4 HET DMS D 203 4 HET CL D 204 1 HET EDO E 201 4 HET EDO E 202 4 HET O6O E 203 27 HET PEG E 204 7 HET EDO E 205 4 HET EDO E 206 4 HET EDO E 207 4 HET EDO E 208 4 HET DMS E 209 4 HET EDO E 210 4 HET EDO E 211 4 HET CL E 212 1 HET NA E 213 1 HET O6O F 201 27 HET PGE F 202 10 HET DMS F 203 4 HET EDO F 204 4 HET EDO F 205 4 HET EDO F 206 4 HET CL F 207 1 HETNAM O6O (8M)-8-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-2-(MORPHOLIN- HETNAM 2 O6O 4-YL)-4H-1-BENZOPYRAN-4-ONE HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM EDO 1,2-ETHANEDIOL HETNAM DMS DIMETHYL SULFOXIDE HETNAM CL CHLORIDE ION HETNAM NA SODIUM ION HETNAM PGE TRIETHYLENE GLYCOL HETSYN EDO ETHYLENE GLYCOL FORMUL 7 O6O 6(C21 H19 N O5) FORMUL 8 PEG 7(C4 H10 O3) FORMUL 11 EDO 27(C2 H6 O2) FORMUL 13 DMS 8(C2 H6 O S) FORMUL 18 CL 6(CL 1-) FORMUL 19 NA 2(NA 1+) FORMUL 58 PGE C6 H14 O4 FORMUL 64 HOH *74(H2 O) HELIX 1 AA1 ARG A 74 VAL A 85 1 12 HELIX 2 AA2 VAL A 85 LYS A 92 1 8 HELIX 3 AA3 ALA A 96 ARG A 100 5 5 HELIX 4 AA4 ASP A 112 ILE A 117 1 6 HELIX 5 AA5 ASP A 122 ASN A 132 1 11 HELIX 6 AA6 ALA A 137 ASN A 156 1 20 HELIX 7 AA7 ASP A 160 ALA A 178 1 19 HELIX 8 AA8 ARG B 74 VAL B 85 1 12 HELIX 9 AA9 VAL B 85 HIS B 93 1 9 HELIX 10 AB1 ALA B 96 ARG B 100 5 5 HELIX 11 AB2 ASP B 112 ILE B 117 1 6 HELIX 12 AB3 ASP B 122 ASN B 132 1 11 HELIX 13 AB4 ALA B 137 ASN B 156 1 20 HELIX 14 AB5 ASP B 160 ALA B 178 1 19 HELIX 15 AB6 ARG C 74 VAL C 85 1 12 HELIX 16 AB7 VAL C 85 HIS C 93 1 9 HELIX 17 AB8 ALA C 96 ARG C 100 5 5 HELIX 18 AB9 ASP C 112 ILE C 117 1 6 HELIX 19 AC1 ASP C 122 ASN C 132 1 11 HELIX 20 AC2 ALA C 137 ASN C 156 1 20 HELIX 21 AC3 ASP C 160 SER C 179 1 20 HELIX 22 AC4 ARG D 74 VAL D 85 1 12 HELIX 23 AC5 VAL D 85 HIS D 93 1 9 HELIX 24 AC6 ALA D 96 ARG D 100 5 5 HELIX 25 AC7 ASP D 104 GLY D 109 1 6 HELIX 26 AC8 ASP D 112 ILE D 117 1 6 HELIX 27 AC9 ASP D 122 ASN D 132 1 11 HELIX 28 AD1 ALA D 137 ASN D 156 1 20 HELIX 29 AD2 ASP D 160 SER D 179 1 20 HELIX 30 AD3 ARG E 74 VAL E 85 1 12 HELIX 31 AD4 VAL E 85 HIS E 93 1 9 HELIX 32 AD5 ALA E 96 ARG E 100 5 5 HELIX 33 AD6 ASP E 112 ILE E 117 1 6 HELIX 34 AD7 ASP E 122 ASN E 132 1 11 HELIX 35 AD8 ALA E 137 ASN E 156 1 20 HELIX 36 AD9 ASP E 160 SER E 179 1 20 HELIX 37 AE1 ARG F 74 VAL F 85 1 12 HELIX 38 AE2 VAL F 85 HIS F 93 1 9 HELIX 39 AE3 ALA F 96 ARG F 100 5 5 HELIX 40 AE4 ASP F 112 ILE F 117 1 6 HELIX 41 AE5 ASP F 122 ASN F 132 1 11 HELIX 42 AE6 ALA F 137 ASN F 156 1 20 HELIX 43 AE7 ASP F 160 ALA F 178 1 19 LINK OD2 ASP E 161 NA NA E 213 1555 1555 3.08 CRYST1 63.810 149.872 63.819 90.00 112.27 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015672 0.000000 0.006419 0.00000 SCALE2 0.000000 0.006672 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016933 0.00000